Stimcell Energetics (STME) Total Debt Growth (1y) (2012 - 2023)
Stimcell Energetics (STME) Total Debt Growth (1y) (2012 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 157.11% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -12.26% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | -1.95% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -2.48% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 0.12% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 19.06% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -5.76% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | -2.49% |
| 10 | Stimcell Energetics | 5.85 Mn | 5.84 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Nov 30, 2023 | -53.01% |
| Aug 31, 2023 | 51.44% |
| May 31, 2023 | 49.35% |
| Feb 28, 2023 | -90.20% |
| Nov 30, 2022 | -91.75% |
| Aug 31, 2022 | -90.93% |
| May 31, 2022 | -88.00% |
| Feb 28, 2022 | -4.26% |
| Nov 30, 2021 | -1.44% |
| Aug 31, 2021 | -5.71% |
| May 31, 2021 | 25.47% |
| Feb 28, 2021 | 132.06% |
| Nov 30, 2020 | 127.99% |
| Aug 31, 2020 | 227.64% |
| May 31, 2020 | -17.79% |
| Feb 29, 2020 | 78.92% |
| Nov 30, 2019 | 68.15% |
| Aug 31, 2019 | 13.89% |
| May 31, 2019 | 98.20% |
| Feb 28, 2019 | 23.60% |